Friday, September 23, 2016

Novartis seeks first-line use for lung cancer drug Zykadia

… patients with ALK-positive non-small cell lung cancer, setting up regulatory filings in …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)